To remove the fluoride in zinc sulfate electrolyte to an appropriate level,mitigate environmental fluoride pollution,and drive the development of the hydrometallurgy industry of zinc,a novel Fe_(3)O_(4)@SiO_(2)@Fe-MIL...To remove the fluoride in zinc sulfate electrolyte to an appropriate level,mitigate environmental fluoride pollution,and drive the development of the hydrometallurgy industry of zinc,a novel Fe_(3)O_(4)@SiO_(2)@Fe-MIL-101 magnetic composite material was successfully synthesized via the one-pot method.Preparation conditions were optimized and structural characterization of this material conducted using FTIR,SEM,EDS,XRD and Hysteresis analysis.The results show that this composite exhibits a more rapid fluoride adsorption dynamics and a higher fluoride adsorption capacity(18.34 mg/g)and its adsorption behavior fitted for the first order dynamic model and the Freundlich isotherm model.The adsorption of fluorine by this composite is mainly physical adsorption according to the mean adsorption energy(1.216 kJ/mol).The interfering ions co-existed in fluoride-containing solutions,like HCO_(3)^(-),NO^(-)and Cl^(-),have a significant effect on fluorine adsorption.This composite has also been proved with magnetism,higher adsorption selectivity and satisfactory reusability.When this composite is employed as an adsorbent for adsorption removing fluoride in zinc sulfate electrolyte,it exhibits higher pH-dependent behavior as well as high fluoride removal efficiency at pH 6.5.展开更多
3-(4-Chlorophenyl)-7-[2-(piperazin-1-yl)ethoxy]-4H-chromen-4-one(CPEO-43)is a derivative of soybean isoflavone(SI),synthesized by introducing a chlorine atom and a piperazine group into the structure of natural SI.In ...3-(4-Chlorophenyl)-7-[2-(piperazin-1-yl)ethoxy]-4H-chromen-4-one(CPEO-43)is a derivative of soybean isoflavone(SI),synthesized by introducing a chlorine atom and a piperazine group into the structure of natural SI.In vitro experiments have demonstrated that CPEO-43 exhibits a notable inhibitory effect on both A549 cells and HCT116 cells.For the further development and utilization of CPEO-43,this study aims to establish and validate a liquid chromatography-tandem mass spectrometry(LC-MS/MS)quantitative analysis method for the pharmacokinetic study of CPEO-43.Normal rats were intragastrically administered different doses(2,6,and 20 mg/kg)of CPEO-43,and blood was taken from the ocular venous plexus at different time points.The blood concentration of CPEO-43 at different time points was determined using LC-MS/MS technology,and the pharmacokinetic parameters of the compound were calculated using the pharmacokinetic software DAS.The results indicated that the established LC-MS/MS method complies with the standards for bioanalytical method validation in the Chinese Pharmacopoeia(CHP)and can be applied to the pharmacokinetic study of CPEO-43.The pharmacokinetic software DAS non-compartmental model was successfully used to calculate the C_(max),T_(max),t_(1/2),AUC_(0-∞),MRTs,CL,and Vd pharmacokinetic parameters of the compound at different doses.The results were as follows:62.0±10.5,222.0±28.7,and 1384.5±376.4 ng/mL;8.5±1.2,6.0±0.0,and 11.0±6.2 h;15.6,15.0,and 18.5 h;1517.8±317.0,5328.7±864.4,and 45556.3±22735.6 ng·h/mL;17.8±1.2,17.7±0.8,and 20.0±3.2 h;1370.3±305.9,1153.5±205.6,and 505.3±179.8 mL/kg/h;30843.0±7458.0,24344.0±5237.0,and 13950.3±5996.9 mL/kg.These characteristics are of great significance for understanding the in vivo process of the drug,formulating dosing regimens,and evaluating the safety and efficacy of the drug.展开更多
基金National Natural Science Foundation of China(21865011)2024 Innovation and Entrepreneurship Project of College Student in Jishou University(JDCX20241122)。
文摘To remove the fluoride in zinc sulfate electrolyte to an appropriate level,mitigate environmental fluoride pollution,and drive the development of the hydrometallurgy industry of zinc,a novel Fe_(3)O_(4)@SiO_(2)@Fe-MIL-101 magnetic composite material was successfully synthesized via the one-pot method.Preparation conditions were optimized and structural characterization of this material conducted using FTIR,SEM,EDS,XRD and Hysteresis analysis.The results show that this composite exhibits a more rapid fluoride adsorption dynamics and a higher fluoride adsorption capacity(18.34 mg/g)and its adsorption behavior fitted for the first order dynamic model and the Freundlich isotherm model.The adsorption of fluorine by this composite is mainly physical adsorption according to the mean adsorption energy(1.216 kJ/mol).The interfering ions co-existed in fluoride-containing solutions,like HCO_(3)^(-),NO^(-)and Cl^(-),have a significant effect on fluorine adsorption.This composite has also been proved with magnetism,higher adsorption selectivity and satisfactory reusability.When this composite is employed as an adsorbent for adsorption removing fluoride in zinc sulfate electrolyte,it exhibits higher pH-dependent behavior as well as high fluoride removal efficiency at pH 6.5.
基金Scientific Research Projects of Hebei North University(Grant No.XJ2024022).
文摘3-(4-Chlorophenyl)-7-[2-(piperazin-1-yl)ethoxy]-4H-chromen-4-one(CPEO-43)is a derivative of soybean isoflavone(SI),synthesized by introducing a chlorine atom and a piperazine group into the structure of natural SI.In vitro experiments have demonstrated that CPEO-43 exhibits a notable inhibitory effect on both A549 cells and HCT116 cells.For the further development and utilization of CPEO-43,this study aims to establish and validate a liquid chromatography-tandem mass spectrometry(LC-MS/MS)quantitative analysis method for the pharmacokinetic study of CPEO-43.Normal rats were intragastrically administered different doses(2,6,and 20 mg/kg)of CPEO-43,and blood was taken from the ocular venous plexus at different time points.The blood concentration of CPEO-43 at different time points was determined using LC-MS/MS technology,and the pharmacokinetic parameters of the compound were calculated using the pharmacokinetic software DAS.The results indicated that the established LC-MS/MS method complies with the standards for bioanalytical method validation in the Chinese Pharmacopoeia(CHP)and can be applied to the pharmacokinetic study of CPEO-43.The pharmacokinetic software DAS non-compartmental model was successfully used to calculate the C_(max),T_(max),t_(1/2),AUC_(0-∞),MRTs,CL,and Vd pharmacokinetic parameters of the compound at different doses.The results were as follows:62.0±10.5,222.0±28.7,and 1384.5±376.4 ng/mL;8.5±1.2,6.0±0.0,and 11.0±6.2 h;15.6,15.0,and 18.5 h;1517.8±317.0,5328.7±864.4,and 45556.3±22735.6 ng·h/mL;17.8±1.2,17.7±0.8,and 20.0±3.2 h;1370.3±305.9,1153.5±205.6,and 505.3±179.8 mL/kg/h;30843.0±7458.0,24344.0±5237.0,and 13950.3±5996.9 mL/kg.These characteristics are of great significance for understanding the in vivo process of the drug,formulating dosing regimens,and evaluating the safety and efficacy of the drug.
